POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for ...

A Japanese borrower that was hit by a record loss is marketing a yen bond deal at the widest spread for corporate hybrid debt ...

Sumeet Bagadia recommends five shares to buy today —Prism Johnson, Pasupati Acrylon Ltd, Dhunseri Investments Ltd, Epigral ...

Sumeet Bagadia recommends five shares to buy today —Prism Johnson, Pasupati Acrylon Ltd, Dhunseri Investments Ltd, Epigral ...

(RTTNews) - The Japanese stock market is trading modestly higher on Monday, adding to the gains in the previous session. The benchmark S&P/ASX 200 is moving to a tad shy of the 38,800 level, following ...

The worst performers of the session were Sumitomo Dainippon Pharma Co Ltd (TYO:4506), which fell 6.13% or 41.00 points to ...

On Friday, JPMorgan (NYSE:JPM) adjusted its stance on Sumitomo Pharma (4506:JP) (OTC: DNPUF) stock, upgrading it from Underweight to Neutral. Accompanying this change in rating, the firm also doubled ...

No identified affiliates for Sumitomo Dainippon Pharma in the 2024 election cycle. Contributions to 527s are not included in the Individuals, PACs, Soft (Indivs), or Soft (Orgs) columns, so the sum of ...

Japan equities were higher at the close on Monday, as gains in the Shipbuilding, Power and Manufacturing sectors led shares ...

(RTTNews) - Reversing the losses in the previous session, the Japanese market is significantly higher on Thursday, following the broadly positive cues from global markets overnight. The Nikkei 225 is ...

DSP-1083 is under clinical development by Sumitomo Pharma and currently in Phase II for Parkinson’s Disease. According to GlobalData, Phase II drugs for Parkinson’s Disease have a 41% phase transition ...